BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25431942)

  • 1. Can genome engineering be used to target cancer-associated enhancers?
    Grimmer MR; Farnham PJ
    Epigenomics; 2014; 6(5):493-501. PubMed ID: 25431942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits.
    Rhie SK; Guo Y; Tak YG; Yao L; Shen H; Coetzee GA; Laird PW; Farnham PJ
    Epigenetics Chromatin; 2016; 9():50. PubMed ID: 27833659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional Enhancers As Master Regulators of Tissue-Specific Gene Regulation and Cancer Development.
    Ko JY; Oh S; Yoo KH
    Mol Cells; 2017 Mar; 40(3):169-177. PubMed ID: 28359147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complexity of epigenetic diseases.
    Brazel AJ; Vernimmen D
    J Pathol; 2016 Jan; 238(2):333-44. PubMed ID: 26419725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The recently identified modifier of murine metastable epialleles, Rearranged L-Myc Fusion, is involved in maintaining epigenetic marks at CpG island shores and enhancers.
    Harten SK; Oey H; Bourke LM; Bharti V; Isbel L; Daxinger L; Faou P; Robertson N; Matthews JM; Whitelaw E
    BMC Biol; 2015 Mar; 13():21. PubMed ID: 25857663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of enhancers in cancer.
    Sur I; Taipale J
    Nat Rev Cancer; 2016 Aug; 16(8):483-93. PubMed ID: 27364481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mining the epigenetic landscape of tissue polarity in search of new targets for cancer therapy.
    Atrian F; Lelièvre SA
    Epigenomics; 2015; 7(8):1313-25. PubMed ID: 26646365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating diverse datasets improves developmental enhancer prediction.
    Erwin GD; Oksenberg N; Truty RM; Kostka D; Murphy KK; Ahituv N; Pollard KS; Capra JA
    PLoS Comput Biol; 2014 Jun; 10(6):e1003677. PubMed ID: 24967590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demystifying the secret mission of enhancers: linking distal regulatory elements to target genes.
    Yao L; Berman BP; Farnham PJ
    Crit Rev Biochem Mol Biol; 2015; 50(6):550-73. PubMed ID: 26446758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics and function of distal regulatory elements during neurogenesis and neuroplasticity.
    Thakurela S; Sahu SK; Garding A; Tiwari VK
    Genome Res; 2015 Sep; 25(9):1309-24. PubMed ID: 26170447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [ Super-enhancers. Are they regulators of regulatory genes of development and cancer?].
    Didych DA; Tyulkina DV; Pleshkan VV; Alekseenko IV; Sverdlov ED
    Mol Biol (Mosk); 2015; 49(6):915-22. PubMed ID: 26710770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DeltaNp63-dependent super enhancers define molecular identity in pancreatic cancer by an interconnected transcription factor network.
    Hamdan FH; Johnsen SA
    Proc Natl Acad Sci U S A; 2018 Dec; 115(52):E12343-E12352. PubMed ID: 30541891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved regulatory element prediction based on tissue-specific local epigenomic signatures.
    He Y; Gorkin DU; Dickel DE; Nery JR; Castanon RG; Lee AY; Shen Y; Visel A; Pennacchio LA; Ren B; Ecker JR
    Proc Natl Acad Sci U S A; 2017 Feb; 114(9):E1633-E1640. PubMed ID: 28193886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transposable Elements and DNA Methylation Create in Embryonic Stem Cells Human-Specific Regulatory Sequences Associated with Distal Enhancers and Noncoding RNAs.
    Glinsky GV
    Genome Biol Evol; 2015 May; 7(6):1432-54. PubMed ID: 25956794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diverse interventions that extend mouse lifespan suppress shared age-associated epigenetic changes at critical gene regulatory regions.
    Cole JJ; Robertson NA; Rather MI; Thomson JP; McBryan T; Sproul D; Wang T; Brock C; Clark W; Ideker T; Meehan RR; Miller RA; Brown-Borg HM; Adams PD
    Genome Biol; 2017 Mar; 18(1):58. PubMed ID: 28351383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extraordinary Cancer Epigenomics: Thinking Outside the Classical Coding and Promoter Box.
    Murtha M; Esteller M
    Trends Cancer; 2016 Oct; 2(10):572-584. PubMed ID: 28741488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phylogenetic and Epigenetic Footprinting of the Putative Enhancers of the Peg3 Domain.
    Kim J; Ye A
    PLoS One; 2016; 11(4):e0154216. PubMed ID: 27104590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TENET 2.0: Identification of key transcriptional regulators and enhancers in lung adenocarcinoma.
    Mullen DJ; Yan C; Kang DS; Zhou B; Borok Z; Marconett CN; Farnham PJ; Offringa IA; Rhie SK
    PLoS Genet; 2020 Sep; 16(9):e1009023. PubMed ID: 32925947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel mRNAs 3' end-associated
    Wang HV; Chekanova JA
    RNA; 2019 Oct; 25(10):1242-1258. PubMed ID: 31311821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic memory at embryonic enhancers identified in DNA methylation maps from adult mouse tissues.
    Hon GC; Rajagopal N; Shen Y; McCleary DF; Yue F; Dang MD; Ren B
    Nat Genet; 2013 Oct; 45(10):1198-206. PubMed ID: 23995138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.